Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 27 peer-reviewed journal articles Updated
Hematology

The Biology and Diagnosis of FHL

At a Glance

Familial hemophagocytic lymphohistiocytosis (FHL) is a genetic disorder where the immune system overreacts, leading to a life-threatening cytokine storm. Doctors diagnose it using the HLH-2004 criteria, looking for specific genetic mutations or clinical signs like high fever and elevated ferritin.

To understand Familial Hemophagocytic Lymphohistiocytosis (FHL), it helps to look at the immune system as a security team. In a healthy body, white blood cells called Natural Killer (NK) cells and T cells act as the “security guards” that find and destroy infected or “activated” cells [1][2]. In FHL, these guards are essentially locked out of their weapon cabinets.

The Biology of the “Cytokine Storm”

The “weapon cabinet” of an immune cell is a secretory lysosome (a small bubble inside the cell) filled with toxic proteins [1][3]. To kill a target, the immune cell must move this bubble to the edge, “dock” it, and release the toxins. In FHL, genetic mutations break different parts of this process:

  • PRF1 (Perforin): This gene provides the “drill” (perforin) that pokes holes in target cells. Without it, the “security guard” can find the target but can’t finish the job [4][2].
  • UNC13D, STX11, and STXBP2: These genes provide the “keys” and “docking equipment” needed to release the toxins from the cell. If they are mutated, the toxins stay trapped inside the immune cell [5][6][7].

Because the immune cells can’t kill their targets, they “panic” and shout for help by releasing massive amounts of inflammatory chemicals called cytokines [8][9]. This “cytokine storm” then hyper-activates another type of immune cell called a macrophage (or histiocyte). Driven into a frenzy, these macrophages become overly aggressive and begin swallowing the body’s own healthy red and white blood cells—a destructive process called hemophagocytosis [10].

How Doctors Diagnose FHL

Diagnosis is often a race against time. Doctors use a set of eight benchmarks called the HLH-2004 criteria [10][11]. A patient is typically diagnosed with HLH if they have a confirmed genetic mutation OR if they meet at least five of the following eight criteria:

  1. Fever: Persistent high temperatures [12].
  2. Spleen enlargement (Splenomegaly): The spleen grows as it fills with overactive immune cells [12].
  3. Low blood counts (Cytopenias): At least two out of three blood components (red cells, white cells, or platelets) are dangerously low [10].
  4. High Triglycerides or Low Fibrinogen: Fats in the blood are too high, or a key clotting protein is too low [10][13].
  5. Hemophagocytosis: A pathologist sees the hyper-activated macrophages “eating” healthy blood cells in the bone marrow, spleen, or lymph nodes [10].
  6. Low or No NK Cell Activity: Lab tests show the “security guards” aren’t killing targets effectively [1].
  7. High Ferritin: Extremely high levels of a protein that stores iron, indicating massive inflammation [14][15].
  8. High Soluble CD25: High levels of a specific marker that shows T cells are “revved up” [16][17].

Diagnostic Challenges and Misdiagnosis

FHL is frequently mistaken for sepsis (a severe body-wide infection) because both cause fever, low blood pressure, and organ failure [18][12]. While sepsis is treated with antibiotics, FHL requires aggressive immune-suppressing therapy to save the child’s life [18][19].

Another major challenge is Central Nervous System (CNS) involvement. In some children, FHL attacks the brain or spinal cord [20][21]. This can cause irritability, seizures, or trouble walking, but sometimes there are no outward signs at all [22][12]. This is why specialists often insist on an MRI and a lumbar puncture (spinal tap) to check for inflammation in the brain fluid [20][23].

Primary vs. Secondary HLH

  • Primary (Familial) HLH: Caused by the inherited genetic mutations described above. Importantly, even though the disease is genetic, the initial “cytokine storm” is very frequently triggered by a common childhood viral infection, such as the Epstein-Barr Virus (EBV) or Cytomegalovirus (CMV), which the genetically impaired immune system cannot clear [24][12]. It is a lifelong condition that requires a stem cell transplant to cure [1][25].
  • Secondary HLH: A reactive condition triggered by a massive infection (like Epstein-Barr Virus), cancer, or autoimmune disease in people without those specific genetic mutations [26][27]. While the symptoms look the same, the long-term treatment is often different.

Common questions in this guide

How is familial hemophagocytic lymphohistiocytosis (FHL) diagnosed?
Doctors use the HLH-2004 criteria to diagnose FHL. A child must either have a confirmed genetic mutation or meet at least five of eight specific clinical benchmarks, such as a persistent fever, an enlarged spleen, or low blood counts.
What causes the cytokine storm in FHL?
A cytokine storm occurs when defective immune cells cannot clear an infection and release massive amounts of inflammatory chemicals. This hyper-activates other immune cells, causing them to aggressively attack the body's own healthy blood cells and organs.
Why might a child with FHL need a lumbar puncture?
FHL can cause severe inflammation in the brain and spinal cord, sometimes without obvious outward symptoms. A lumbar puncture, or spinal tap, allows doctors to check the brain fluid for hidden inflammation and ensure the central nervous system is closely monitored.
Why is FHL often misdiagnosed as sepsis?
FHL shares many early warning signs with severe infections like sepsis, including high fever, low blood pressure, and organ failure. However, while sepsis is treated with antibiotics, FHL requires immediate, aggressive immune-suppressing therapy to calm the overactive immune system.
What is the difference between primary and secondary HLH?
Primary (or familial) HLH is caused by inherited genetic mutations, though the initial episode is often triggered by a common viral infection. Secondary HLH causes identical symptoms and organ damage but occurs in people without those specific genetic mutations, usually in response to infection or cancer.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which of the eight HLH-2004 criteria does my child currently meet?
  2. 2.Has my child had a lumbar puncture and an MRI to check for Central Nervous System (CNS) involvement?
  3. 3.What specific genetic mutations were found, and how do they affect the 'killing' function of my child's immune cells?
  4. 4.How are you differentiating this from a severe infection or sepsis?
  5. 5.Can we perform a CD107a flow cytometry test to check for degranulation defects while we wait for genetic results?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (27)
  1. 1

    Clinical, immunological and genetic findings in patients with UNC13D deficiency (FHL3): A systematic review.

    Amirifar P, Ranjouri MR, Abolhassani H, et al.

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2021; (32(1)):186-197 doi:10.1111/pai.13323.

    PMID: 32679608
  2. 2

    Accuracy of flow cytometric perforin screening for detecting patients with FHL due to PRF1 mutations.

    Abdalgani M, Filipovich AH, Choo S, et al.

    Blood 2015; (126(15)):1858-60 doi:10.1182/blood-2015-06-648659.

    PMID: 26450956
  3. 3

    Molecular Genetics Diversity of Primary Hemophagocytic Lymphohistiocytosis among Polish Pediatric Patients.

    Bąbol-Pokora K, Wołowiec M, Popko K, et al.

    Archivum immunologiae et therapiae experimentalis 2021; (69(1)):31 doi:10.1007/s00005-021-00635-4.

    PMID: 34677667
  4. 4

    Spectrum of Atypical Clinical Presentations in Patients with Biallelic PRF1 Missense Mutations.

    Tesi B, Chiang SC, El-Ghoneimy D, et al.

    Pediatric blood & cancer 2015; (62(12)):2094-100 doi:10.1002/pbc.25646.

    PMID: 26184781
  5. 5

    Functional role of UNC13D in immune diseases and its therapeutic applications.

    Duong VT, Lee D, Kim YH, Oh SO

    Frontiers in immunology 2024; (15()):1460882 doi:10.3389/fimmu.2024.1460882.

    PMID: 39469717
  6. 6

    Munc18-2 is required for Syntaxin 11 Localization on the Plasma Membrane in Cytotoxic T-Lymphocytes.

    Dieckmann NM, Hackmann Y, Aricò M, Griffiths GM

    Traffic (Copenhagen, Denmark) 2015; (16(12)):1330-41 doi:10.1111/tra.12337.

    PMID: 26771955
  7. 7

    SM protein Munc18-2 facilitates transition of Syntaxin 11-mediated lipid mixing to complete fusion for T-lymphocyte cytotoxicity.

    Spessott WA, Sanmillan ML, McCormick ME, et al.

    Proceedings of the National Academy of Sciences of the United States of America 2017; (114(11)):E2176-E2185 doi:10.1073/pnas.1617981114.

    PMID: 28265073
  8. 8

    Hemophagocytic Lymphohistiocytosis.

    Al-Samkari H, Berliner N

    Annual review of pathology 2018; (13()):27-49 doi:10.1146/annurev-pathol-020117-043625.

    PMID: 28934563
  9. 9

    Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy.

    Griffin G, Shenoi S, Hughes GC

    Best practice & research. Clinical rheumatology 2020; (34(4)):101515 doi:10.1016/j.berh.2020.101515.

    PMID: 32387063
  10. 10

    Extreme Hypertriglyceridemia in an Infant with Hemophagocytic Lymphohistiocytosis and Hydroxycobalamin Deficiency.

    Dokmanović L, Krstovski N, Lazić J, et al.

    Srpski arhiv za celokupno lekarstvo 2015; (143(11-12)):744-7 doi:10.2298/sarh1512744d.

    PMID: 26946773
  11. 11

    Can we truly diagnose adult secondary hemophagocytic lymphohistiocytosis (HLH)? A critical review of current paradigms.

    Naymagon L

    Pathology, research and practice 2021; (218()):153321 doi:10.1016/j.prp.2020.153321.

    PMID: 33418346
  12. 12

    Neurological symptoms of familial hemophagocytic lymphohistiocytosis type 2.

    Wang J, Tuo H, Wu L, et al.

    Journal of integrative neuroscience 2020; (19(1)):131-135 doi:10.31083/j.jin.2020.01.1250.

    PMID: 32259894
  13. 13

    Hypofibrinogenemia Is Associated With Poor Outcome and Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome in Pediatric Severe Sepsis.

    Signoff JK, Fitzgerald JC, Teachey DT, et al.

    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 2018; (19(5)):397-405 doi:10.1097/PCC.0000000000001507.

    PMID: 29470247
  14. 14

    Reevaluating the role of ferritin in the diagnosis of adult secondary hemophagocytic lymphohistiocytosis.

    Naymagon L, Tremblay D, Mascarenhas J

    European journal of haematology 2020; (104(4)):344-351 doi:10.1111/ejh.13391.

    PMID: 31991015
  15. 15

    Weathering a Cytokine Storm: A Case of EBV-Induced Hemophagocytic Lymphohistiocytosis.

    Shaw TY, Schivo M

    Journal of investigative medicine high impact case reports 2016; (4(2)):2324709616647409 doi:10.1177/2324709616647409.

    PMID: 27200381
  16. 16

    Clinical significance of cerebrospinal fluid soluble CD25 in pediatric hemophagocytic lymphohistiocytosis with central nervous system involvement.

    Ou W, Ma H, Wei A, et al.

    Pediatric blood & cancer 2022; (69(8)):e29712 doi:10.1002/pbc.29712.

    PMID: 35441804
  17. 17

    Proteomics Reveals Differential Diagnosis Biomarkers Between Sepsis and Hemophagocytic Syndrome.

    Martin-Pestana D, Azkargorta M, Pilar-Orive FJ, et al.

    Biomedicines 2025; (13(12)) doi:10.3390/biomedicines13123113.

    PMID: 41463121
  18. 18

    Screening of hemophagocytic lymphohistiocytosis in children with severe sepsis in pediatric intensive care.

    El-Sayed ZA, El-Owaidy RH, Khamis MA, Rezk AR

    Science progress 2021; (104(3)):368504211044042 doi:10.1177/00368504211044042.

    PMID: 34519554
  19. 19

    Similar but not the same: Differential diagnosis of HLH and sepsis.

    Machowicz R, Janka G, Wiktor-Jedrzejczak W

    Critical reviews in oncology/hematology 2017; (114()):1-12 doi:10.1016/j.critrevonc.2017.03.023.

    PMID: 28477737
  20. 20

    Central nervous system involvement in pediatric hemophagocytic lymphohistiocytosis: A single-center descriptive study of clinical features, neurodiagnostic findings, and outcomes.

    Nath M, Vagrecha A, Roliz AH, et al.

    Clinical hematology international 2026; (8(1)):26-36 doi:10.46989/001c.155719.

    PMID: 41726770
  21. 21

    Clinical and neuroimaging features of familial hemophagocytic lymphohistiocytosis.

    Alkaphoury MG, Mohammad SA, Farghal NBE, et al.

    Pediatric radiology 2026; (56(2)):443-454 doi:10.1007/s00247-025-06454-5.

    PMID: 41251694
  22. 22

    Exploring the Intersection of Isolated-CNS Hemophagocytic Lymphohistiocytosis and Pediatric Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids.

    Debinski C, Goergen S, McLean C, et al.

    Journal of child neurology 2021; (36(11)):935-942 doi:10.1177/08830738211009654.

    PMID: 34056941
  23. 23

    Biomarkers in Pediatric Hemophagocytic Lymphohistiocytosis With Central Nervous System Involvement: A Cohort Study.

    Zhao Y, Ou W, Wei A, et al.

    Journal of pediatric hematology/oncology 2024; (46(7)):364-372 doi:10.1097/MPH.0000000000002937.

    PMID: 39145632
  24. 24

    ST2 contributes to T-cell hyperactivation and fatal hemophagocytic lymphohistiocytosis in mice.

    Rood JE, Rao S, Paessler M, et al.

    Blood 2016; (127(4)):426-35 doi:10.1182/blood-2015-07-659813.

    PMID: 26518437
  25. 25

    History of Hemophagocytic Lymphohistiocytosis.

    Janka GE

    Advances in experimental medicine and biology 2024; (1448()):9-19 doi:10.1007/978-3-031-59815-9_2.

    PMID: 39117804
  26. 26

    Genetics of Primary Hemophagocytic Lymphohistiocytosis.

    Karageorgos S, Platt AS, Bassiri H

    Advances in experimental medicine and biology 2024; (1448()):75-101 doi:10.1007/978-3-031-59815-9_7.

    PMID: 39117809
  27. 27

    Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases.

    Kim WY, Montes-Mojarro IA, Fend F, Quintanilla-Martinez L

    Frontiers in pediatrics 2019; (7()):71 doi:10.3389/fped.2019.00071.

    PMID: 30931288

This page provides educational information on the biology and diagnosis of FHL. It is not a substitute for professional medical advice, and you should always consult your child's medical team for accurate diagnostic testing and care.

Get notified when new evidence is published on Familial hemophagocytic lymphohistiocytosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.